Long-Term Vitamin K Antagonists and Cancer Risk

@article{Shurrab2019LongTermVK,
  title={Long-Term Vitamin K Antagonists and Cancer Risk},
  author={M. Shurrab and K. Quinn and A. Kitchlu and C. Jackevicius and D. Ko},
  journal={American Journal of Clinical Oncology},
  year={2019},
  volume={42},
  pages={717 - 724}
}
  • M. Shurrab, K. Quinn, +2 authors D. Ko
  • Published 2019
  • Medicine
  • American Journal of Clinical Oncology
  • Supplemental Digital Content is available in the text. Objectives: Vitamin K antagonists (VKAs) remain one of the most commonly used anticoagulation therapies. The potential anticancer effect of long-term use of VKAs has been a matter of debate with conflicting results. Our goal was to perform a systematic review and meta-analysis examining the association between long-term VKAs use and cancer risk. Methods: Systematic searches of multiple major databases were performed from inception until… CONTINUE READING

    Topics from this paper.

    PREVENTING CHRONIC DISEASE

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 46 REFERENCES
    Meta-analysis in clinical trials.
    • 27,254
    • PDF
    An introduction to meta-analysis.
    • 2,985
    • PDF
    Conducting Meta-Analyses in R with the metafor Package
    • 5,743
    • PDF